Class Action Lawsuit

Week Adjourned: 4.27.12 – Bumble Bee Tuna, Vita Coco, Citizens Bank

The weekly wrap on top class action lawsuits and settlements, for the week ending April 27, 2012. Top stories on Bumble Bee Tuna, Vita Coco and Citizens Bank.

Top Class Actions

Bumble Bee Got Stung This Week—with a consumer fraud class action. Yes, it’s true, I’m afraid. The worker bee of tinned seafood (I have never understood what a bumble bee is doing on a tin of tuna) is facing allegations that it repeatedly violated California and federal laws that require companies to use truthful, accurate information on their packaged food labels. (Shame, shame.)

At specific issue in the Bumble Bee lawsuit are the health claims made by Bumble Bee Foods pertaining to its tinned seafood products.

The alleged violations include failing to disclose that Omega-3 has no established Daily Value under FDA regulations, and a failure to properly disclose the high levels of fat, saturated fat and cholesterol in Bumble Bee food products on the packaging and labeling.

The Bumble Bee class action lawsuit states “To appeal to consumer preferences, Bumble Bee has repeatedly made unlawful nutrient claims on products containing disqualifying levels of fat, sodium and cholesterol. These nutrient content claims were unlawful because they failed to include disclosure statements required by law that are designed to inform consumers of the inherently unhealthy nature of those products. ”

The lawsuit states, by way of example, “Tuna Salad Original with Crackers Kit” has 18g of fat per labeled serving, but does not bear a statement that fat exceeding the specified level is present.

The Bumble Bee Foods lawsuit is a nationwide class seeking to represent consumers who purchased Bumble Bee products labeled “Rich in Natural Omega-3” or “Excellent Source Omega-3” within the last 4 years. The California-based law firm of Pratt & Associates is representing the plaintiffs in this class action.

Top Settlements

Something a Little Loco ‘Bout Vita Coco…While we’re on the subject of consumer fraud—a preliminary settlement has been reached in the consumer fraud class action lawsuit against All Market Inc. d/b/a Vita Coco. You must remember this—(a kiss is just a—no—wrong song sheet)—it’s the miracle vitamin water. After all, it does everything including taking the garbage out.

If you purchased Vita Coco Products between August 10, 2007 and the present you may be entitled to a payment from a class action settlement.

Under the terms of the settlement, Vita Coco agreed to set aside $1 million (the “Cash Settlement Fund”), which will provide for payments to Settlement Class Members who timely file claims of up to a maximum of $25.00 with Proof of Purchase (as defined in the Stipulation) and $6.00 without Proof of Purchase. Vita Coco has agreed to provide $1 million current retail value in product vouchers, which can be redeemed by Settlement Class Members who timely file claims in lieu of cash up to a maximum of $36.00 with Proof of Purchase or $8.00 without Proof of Purchase.

There are other conditions the company has agreed to as part of the Vita Coco settlement, which you can find here along with your options as a class member- e.g., do you want to remain in the settlement class, or would you like to be excluded…where do you obtain forms, those kinds of things.

This settlement is only preliminary. The Court will hold a hearing on August 22, 2012 to consider whether to grant final approval of the settlement and whether to grant Class Counsel’s (as defined in the Stipulation) request for attorneys’ fees, reimbursement of expenses and incentive awards for class representatives.

Good Citizens They Weren’t but…It’s Payback Time! Citizens Bank has agreed to pay $137.5 million (Cha Ching!) to settle a class action lawsuit which accused the bank of manipulating its customers’ debit card and ATM transactions in order to generate excess overdraft fee revenues for the bank.

The lawsuit is part of multidistrict litigation involving more than 30 different banks entitled In re Checking Account Overdraft Litigation, case number 09-cv-02036, is pending before U.S. District Judge James Lawrence King in Miami. Citizens Bank is part of Citizens Financial Group which, through RBS Citizens, N.A. and Citizens Bank of Pennsylvania, operates more than 1,500 retail banking branches throughout the Northeast, the Mid-Atlantic and the Mid-West.

The Citizens Bank lawsuit claims that the bank employed software programs designed to extract the greatest possible number of overdraft fees from its customers. According to the lawsuit, Citizens Bank re-sequenced its customers’ debit card and ATM transactions by posting them in highest-to-lowest dollar amount, rather than in the actual order in which the transactions were initiated by the customers and authorized by the bank. According to the lawsuit, this internal bookkeeping practice resulted in Citizens’ customers being charged substantially more in overdraft fees than if their debit card and ATM transactions had been posted in the order in which they were authorized by the bank.

I wonder if that settlement amount includes interest?

And on that note—happy weekend. Where’s the gin got to…

Week Adjourned: 4.20.12 – Purina Dog Treats, FEMA Trailers, Allstate Insurance

The weekly wrap on top class action lawsuits and settlements for the week ending April 20, 2012. Top stories include Purina dog treats, Allstate Insurance and Hurricane Katrina FEMA trailers.

And this week—it’s business behaving badly…

Top Class Actions

If you have a dog, read this… A $5 million defective products class action lawsuit has been filed against Nestlé Purina Petcare Co, alleging the company’s Waggin’ Train Yam Good chicken-wrapped treats causes kidney failure in dogs.

The Waggin’ Train Yam Good dog treats lawsuit, filed by Dennis Adkins from Illinois, claims his 9-year-old Pomeranian dog became sick and died from kidney failure three days after eating Waggin’ Train Yam Good chicken-wrapped treats. Adkins said he didn’t give his dog more than the recommended one treat per day, and his other dog did not eat the treats and didn’t get sick. Walmart, where the dog treats were sold, is also a defendant in the lawsuit.

As reported by Reuters Legal, in 2011, the U.S. Food and Drug Administration (FDA) issued a cautionary warning to consumers about a potential link between dog illnesses and chicken jerky-based products imported from China. None of the products were recalled, and no specific brands were mentioned in the FDA warning. Unbelievable? No, sadly not.

Top Settlements

The fallout from Hurricane Katrina just goes on and on…this week, a $14 million settlement was reached in the defective products Hurricane Katrina FEMA trailer class action brought by victims of Hurricane Katrina against 21 companies who manufactured those infamous FEMA trailers.

The companies manufactured government-issued trailers for storm victims after Hurricane Katrina, and the FEMA trailer lawsuit claims that those trailers contained hazardous materials. As a consequence, the occupants were exposed to toxic fumes.

Attorneys for the plaintiffs told media on Tuesday that the trailer manufacturers or their insurers will pay a total of $14.8 million to resolve the claims without any admission of wrongdoing. The proposed settlement could benefit tens of thousands of Gulf Coast residents who lived in the travel trailers, which were provided by the Federal Emergency Management Agency (FEMA) after hurricanes Katrina and Rita in 2005, the Associated Press reports.

Early Bird Renewals Catch Bad Faith Insurance Settlement at Allstate. A proposed settlement has been reached this week in a bad faith insurance class action that accuses Allstate of deceptive business practices.

What did they do, you ask? Well allegedly, Allstate Insurance Company and Allstate Indemnity Company (collectively “Allstate”) sent their motor vehicle insureds deceptive motor vehicle insurance renewal bills in order to induce Allstate’s insureds to pay their renewal premium in full a month before the were premiums were actually due.

If you are affected by this potential settlement, you can find out more here. If you have received a Notice, Allstate’s records indicate you are a member of the class.

The Court has given its preliminary approval to the Settlement, and has ordered that a Notice be sent to all Settlement Class Members. Under the terms of the settlement a sum of $2,727,555 would be provided to pay for claims to those class memers who submit valid claims. The payment amount will consist of 30 days of interest at an annual rate of 7 percent simple interest on the payments of the stated “pay in full” amounts that you made on or before the “due date” indicated on the bill.

The judge presiding over this case has deemed that everyone who fits this description is a class member: all Allstate California motor vehicle insureds who from January 1, 2002 through December 31, 2005 received Allstate motor vehicle insurance renewal bills indicating a “due date” for payment approximately one month before the date the policy was to renew, and who paid the stated “pay in full” amount on or before the “due date” on the bill.

And on that happy note—that’s a wrap. I hear the ice-cubes calling my name…

Week Adjourned: 4.13.12 (Muscle Milk, Risperdal, GameStop)

A weekly wrap up of the top class action lawsuits and class action settlements for the week of April 13, 2012; top stories this week: Muscle Milk, Risperdal and GameStop

Top Class Actions

This Week’s Mantra—Cav-e-at Emp-tor…Cav-e-at Emp-tor! Throw that right in there with ‘om shanti shanti shanti om’ at your next yoga class and see what happens…

This week, a consumer fraud class action against Cytosport got greenlit by a judge in the United States District Court for the Northern District of California. Bottom line, the company is accused of engaging in false advertising of its popular Muscle Milk line of products. (I’d be wary of a product with that name. What does it mean?)

According to the Muscle Milk class action lawsuit, to increase sales figures, Cytosport intentionally misrepresents the purported health benefits of Muscle Milk, and actively draws consumer attention away from the significant amount of saturated fats in the products.

The lawsuit alleges that Cytosport profits significantly from its deceptive marketing of Muscle Milk (well, why else would they do it?) because the company’s depiction of the products as “healthy” plays into consumers’ increasing interest in health-conscious foods.

In its decision, the Court explained that a “reasonable consumer would be likely to believe that the drink contains unsaturated, not saturated fats. The drink container also states that it is a ‘nutritional shake.’ This representation … contributes to a sufficient claim of deceptive product labeling … the injury to the consumer class as a whole could be substantial, even if the injury to individual consumers is minimal. No benefit is served by false and misleading advertising.” Well, that’s not entirely true —the company has benefited, allegedly.

Hey, maybe Lay’s Potato Chips and Muscle Milk can team up for some co-op ads, eh? Mmmaybe not.

Top Settlements

Costliest Ad Campaign Ever? This settlement is one for the books, if it goes through. According to media reports out this week, Johnson & Johnson (J&J) may have to stump up a cool $1.25 billion in penance for deceptive marketing of its atypical antipsychotic Risperdal, in Arkansas. The Risperdal settlement, ordered by a judge in Arkansas, is one of the larger J&J may have to pay for deceptive marketing of the drug. But it’s worth noting that J$J will likely appeal.

According to a report by Bloomberg, it took jurors in state court in Little Rock, not more than three hours to deliver their verdict: J&J and its Janssen unit were guilty of taking part in “false or deceptive acts.”

These “acts” date back to 2003, when the company allegedly sent what’s known as “Dear Doctor” letter to no less than 6,000 doctors in the state, allegedly claiming Risperdal is safer than competing drugs used in the state. ”

FYI—Risperdal carries a warning stating that older adults with dementia who take antipsychotic medications may have an increased risk of death, stroke or mini-stroke during treatment.

The state of Arkansas is seeking more than $1.25 billion in penalties over the Risperdal marketing campaign, and a judge will decide later whether to fine J&J,” Bloomberg reports.

This is the third case in which states allege J&J hid the risks associated with Risperdal—and tricked Medicaid regulators into paying more than they should have for the medicine. And it is the third case in which a jury has found against the drug-maker. Juries in Louisiana and South Carolina have also found that J&J’s marketing of Risperdal violated consumer-protection laws. (Bloomberg)

GameStop GamePlaying Over. And one more time for good measure—yet another consumer fraud class action, this one a settlement against retailer GameStop, who stands accused of “deceptive and misleading practices” with its used game sales and paid downloadable content.

Filed two years ago, by James Collins of California, the GameStop lawsuit claims GameStop sells used copies of games that require users to purchase downloadable content for features, even though the packaging for those games advertise that content as free.

According to the lawsuit, several games include one-time-use codes for consumers to download free content, but they require users to purchase that same content if the code has been redeemed, as is the case for many used copies of games. “As a result of GameStop’s deceptive and misleading practices, consumers who purchase used games from GameStop unknowingly find that they must pay an additional fee to access the full game they thought they purchased,” the lawsuit states.

According to the terms of the settlement, for the next two years GameStop must post online warnings and in-store signs (in California, where the lawsuit was filed) next to used games to remind consumers that certain downloadable content may require an additional purchase.

Consumers in California who have purchased a qualifying used game and are enrolled in GameStop’s PowerUp Rewards Program may be able to recover the $15 they might have paid for downloadable content. Also, they could be eligible to receive a $10 check and a $5 coupon. Non-PowerUp Rewards members can receive a $5 check and a $10 coupon. FYI—this settlement only applies to California customers.

And on that happy note—that’s a wrap. I hear the ice-cubes calling my name…om caveat emptor caveat emptor om…

Week Adjourned: 4.6.12 – Lay’s Potato Chips, Groupon, Medtronic

Weekly wrap-up of top class action lawsuits and class action settlements, for the week ending April 6, 2012.

Top Class Actions

Potato Chips are Healthy! Seriously–it’s time for the shovel on this one folks. A federal consumer fraud class action lawsuit filed against PepsiCo and its subsidiary Frito-Lay this week, claims they mislead customers by “misbranding” their potato chips as healthy because they contain “0 grams of Trans Fat.” Call me old-fashioned, but I think that’s a bit of leap. Like—what exactly happened in the potato-chip-making process that suddenly makes the king of junk food healthy?

Not much, it seems. The Frito-Lay lawsuit contends the advertising does not point out that every 50 chips contains more than 13g of fat. Well, hello!

Specifically, the class action lawsuit accuses Frito-Lay of violating federal and California laws that require companies to provide truthful, accurate information on the labels of packaged foods.

“As consumer preferences have begun to favor healthier options, Defendants have chosen to implement a health and wellness strategy to reposition their products as a healthy option,” the Frito-Lay fraud class action lawsuit states. “Defendants recognize that health claims drive food sales and actively promote the purported health benefits of their Misbranded Food Products, notwithstanding the fact that such promotion violates California and federal law.”

Among the deceptive health claims included in the Lay’s potato chips advertising are that the chips are “prepared with healthier oils,” that Frito-Lay’s snack chips “contain 0 grams of Trans Fat, are low in saturated fat and cholesterol-free,” and that the chips contain “good stuff like potatoes, which naturally contain vitamin C and essential minerals.”

Ok. Nothing short of an Easter miracle is going to make potato chips healthy. Come on.

The consumer fraud class action also notes that Frito-Lay tells consumers that “Snacking is an important part of a healthy diet” and that “Snacks may benefit special populations including people with diabetes, children and adolescents, older adults, and pregnant women.” At a loss for words at this point.

According to the lawsuit, “If a manufacturer is going to make a claim on a food label, the label must meet certain legal requirements that help consumers make informed choices and ensure that they are not misled.” However, PepsiCo and Frito-Lay “have made, and continue to make, false and deceptive claims” in violation of state and federal law. Furthermore, lawyers for the plaintiffs contend, “Misbranded food is worthless as a matter of law, and purchasers of misbranded food are entitled to a refund of their purchase price.”

The Frito-Lay consumer fraud class action lawsuit is brought on behalf of all California consumers who, have purchased Frito-Lay potato chips labeled “0 grams Trans Fat” but which contained more than 13 grams of fat per 50 grams and purchased those chips within the past four years.

The lawsuit is seeking damages, restitution or disgorgement, as well as a cease and desist order banning the companies from selling their allegedly misbranded food products. (Just in case the collective consumer wisdom accumulated over the past 50 years fails to kick in?)

Raw Deal of the Day? Somewhere in Groupon’s tagline, the word beleaguered should appear. To say this company is beset with lawsuits would be an understatement. This week, it’s a securities class action alleging it released “materially false and misleading statements” regarding its financial results. The Groupon lawsuit seeks class-action status on behalf of shareholders who acquired Groupon shares between November 4, 2011 and March 30, 2012.

The lawsuit also claims Groupon’s revenue and growth were overstated, and the company “was not nearly resistant to competition as suggested by defendants.”

The fellow who filed the suit, Fan Zhang, claims that Groupon “failed to disclose negative trends” that would have affected its IPO pricing of 35 million shares of common stock at $20 per share.

Short version—Fan Zhang reportedly bought 3,000 shares of Groupon at an estimated $61,800 in February, then sold those shares in March at a $9,000 loss. Ouch! The lawsuit goes on to state “Groupon’s internal controls were so poor and inadequate that Groupon’s reported results were not reliable.”

The defendants include Groupon Chief Executive Andrew Mason and several banks that helped take the company public, including the lead IPO underwriters Credit Suisse, Goldman Sachs and Morgan Stanley. Um. None of those banks are strangers to lawsuits. Oh well, if you’re heading into a lawsuit like this, best to have some experienced people with you…

Top Settlements

And While we’re on the Subject of Groupon… they agreed to settle a consumer fraud class action this week to the tune of $85.million. The Groupon lawsuit, filed by disgruntled customers, (who else?) alleges that the expiration dates on Groupon coupons are illegal.

The proposed settlement applies to anyone who purchased Groupon vouchers before December 1, 2011. Under the terms of the settlement, the class members can either redeem the coupons beyond their expiration date or, if they are unable to do so, obtain a refund from the $8.5 million fund. Residents in some states can seek refunds only for vouchers sold after Aug. 22, 2010.

And, for the next three years, also as part of the settlement, Groupon has agreed not to sell more than 10 percent of its daily deals with an expiration date of less than 30 days after their issue date.

According to Bloomberg.com, the settlement pertains to no less than 17 lawsuits filed against the daily deals dealer, which were subsequently consolidated. The plaintiffs claimed Groupon and various retailers violate federal and state consumer protection laws with improper expiration dates and other provisions for the vouchers, such as the requirement that they be used in a single transaction.

“Groupon effectively creates a sense of urgency among consumers to quickly purchase ‘groupon’ gift certificates by offering ‘daily deals’ for a short amount of time,” according to the first lawsuit which was filed in 2011. “Consumers therefore feel pressured and are rushed into buying the gift certificates and unwittingly become subject to the onerous sales conditions.”

New Meaning to Graft? And then there’s Medtronic. What can we say about these guys—that’s good? Not much really. Although this news is good—for investors. The medical equipment company has agreed to pony up $85 million to settle investors’ claims regarding stock fraud.

The securities class action lawsuit claims that the investors were misled by company leaders on the off-label uses of the company’s highly controversial Medtronic Infuse bone graft. This product is troubling from a number of angles.

The Medtronic stock fraud settlement still awaits final documentation and court approval.

The lawsuit, filed in 2008 by the Minneapolis Firefighters Relief Association, claims that Medtronic’s officers and directors misled investors through a nearly decade-long campaign to illegally promote Infuse for uses not approved by the Food & Drug Administration.

Sales and future growth of the graft were “driven by misconduct that invited, and ultimately brought about, the scrutiny of federal regulators and an abrupt decline in sales,” according to a case brief by attorneys for the investors. As a result, revenues declined, so did the value of shares, which fell to $31.60 from $57.86.

And on that happy note—that’s a wrap. Happy Good Friday everyone.

Wait—is that a bunny on my lawn?

Week Adjourned: 3.30.12 (Barefoot Running, LG Electronics, Deutsche Bank)

The weekly wrap-up of class action lawsuits and class action settlements for the week ending March 30, 2012.

Top Class Actions

Barefoot running benefits nothing more than barefaced lies? Well, it remains to be seen, but certainly there’s doubt over its merits—though no doubts re: its ugliness—and allegations of injury resulting from the barefoot running shoe. (Is it really a shoe?) A consumer fraud class action lawsuit was filed this week against Vibram USA Inc and Vibram FiveFingers LLC, alleging the company used deceptive statements about the health benefits of barefoot running.

Filed on behalf of Florida resident Valerie Bezdek, the Barefoot Running Shoes lawsuit alleges that 1) health benefits claims Vibram FiveFingers has used to promote the shoes are deceptive; 2) that FiveFingers may increase injury risk as compared to running in conventional running shoes, and even when compared to running barefoot; 3) that there are no well-designed scientific studies that support FiveFingers claims.

“Given that Defendant’s advertising and marketing equates barefoot running with running in FiveFingers, Defendant’s uniform deceptive statements about barefoot running are also deceptive statements about Five Fingers,” the lawsuit claims.

The lawsuit also states that sales of the Vibram FiveFingers shoes have grown an average of 300 percent a year for the last five years and approached $70 million in 2011. That’s certainly not chump change.

LG TV lifespans less than expected. You know, you could make the argument that defective products help the market economy—something breaks—you go buy a new one—right? Well, not according to some disgruntled LG consumers. They filed a federal class action lawsuit against LG Electronics USA, alleging that the electronics manufacturer’s plasma and LCD Television sets are defective, impacting the lifespan of the televisions. And they are not prepared to go out and buy new sets. Can you blame them?

The LG Electronics class action lawsuit seeks to represent anyone else who purchased certain defective LG televisions in the state of Nevada. Class televisions include but are not limited to models 32LC2D, 37LC2D, 42LC2D, 42PC3D, 42PC3DV, 47LC7DF and 50PC3D.

The lawsuit alleges that the televisions are defective in that they contain internal components called printed wiring boards (also known as printed circuit boards) that prematurely fail during normal operation of the televisions (the “defect”). The defect, which was present upon delivery and which manifests itself over time, ultimately results in the failure of the televisions themselves well before the end of their expected useful life, and rendering the televisions unsuitable for their principal and intended purpose. I’m guessing that’s watching TV…

Top Settlements

Danke schön, Deutsche Bank (not). It’s the financial mess that never ends—though you have to admit, it’s given the document shredding industry cause for a few high-five’s… A preliminary settlement was announced this week in the lawsuit pending against Deutsche Bank—with the German financial house agreeing to pony up a paltry $32.5 million to settle claims that it lied about the quality of home loans underlying the securities it sold. (Well Hel-lo. And where in the settlements line-up is this one?)

The investors that sued include the Massachusetts Bricklayers and Masons Trust Funds. They have filed a motion for preliminary approval of the Deutsche Bank settlement in federal court in Central Islip, New York.

“The proposed settlement will provide a substantial monetary benefit to the settlement class,” court papers state.

According to the lawsuit, and as reported by Bloomberg.com, in 2006, the plaintiffs bought from Deutsche Bank so-called pass-through certificates that gave them the right to the payments on the underlying home loans. The offering documents contained misstatements about loan underwriting standards, property appraisals, loan-to-value ratios and credit ratings on the certificates, according to the complaint. At the same time Deutsche Bank was selling the securities, it was profiting from credit-default swaps by wagering that loans like those underlying the certificates would decline in value, the investors claim.

The lawsuit also states “More than 49 percent of the loans underlying one certificate series were delinquent or foreclosed on,” the investors said. The tranche the Massachusetts Bricklayers and Masons Trust Funds, the lead plaintiff, bought “has already realized cumulative principal losses.”

The investors also claim that had a sale been done in 2008 when the lawsuit was filed, they would have netted between 70 and 80 cents on the dollar. “The certificates are no longer marketable at prices anywhere near the price paid,” the lawsuit states. So I guess $32.5 million doesn’t look so bad now.

OK–That’s a wrap. Happy Friday everyone–Mickey Mouse says it’s Martini Time! (and may one of us hit #MegaMillions!)

Week Adjourned: 3.23.12 (GoDaddy, Yo-Plus Yogurt, Honda Hybrid)

Lots of consumer fraud class action lawsuits this week in our weekly wrap up of the top class action lawsuits and settlements, for the week ending March 23, 2012.

Top Class Actions

Bit of a theme here this week—consumer fraud.

And this one is for anyone who has ever registered at least 5 domain names, thinking they were getting a bargain. GoDaddy, the Internet domain registration giant, is facing a possible consumer fraud class action lawsuit over its allegedly illegal charges for private registration services it advertises as being free.

The GoDaddy lawsuit claims that while GoDaddy offers free private domain registration to customers who register five or more domain names at the same time, when those customers go to renew their domains they are charged at the regular price.

The lawsuit, filed by Florida company WineStyles, states “By suggesting that the value of ‘FREE’ Private Registration was $9.99/yr, and that the ‘FREE’ service had ‘NO LIMIT!’, GoDaddy represented that the ‘FREE’ Private Registration services would be for the lifetime of the domain name, and Plaintiff (and on information and belief, the Class) believed this to be the case.”

The GoDaddy lawsuit also states that renewal notices sent to customers do not indicate that the privacy services would no longer be free upon renewal. And, the plaintiffs allege “Throughout the class period, GoDaddy provided wholly inadequate disclaimers on GoDaddy.com, which reiterated the ‘FREE’ offer but never mentioned to Customers that the Private Registration service would be automatically renewed by GoDaddy at the full price applicable to single domain name purchases, instead of for ‘FREE.’”

The proposed consumer fraud lawsuit is brought on behalf of customers who registered 5 or more domains, received the “free” private registration, and then were charged a fee for the proxy services when they renewed between March 19, 2006 and the present.

Yo! – Yogurt-eaters of California! You may be affected by a consumer fraud class action lawsuit facing General Mills that alleges the company falsely advertised the digestive health benefits of its Yo-Plus® brand of yogurt.

The lawsuit is called Johnson v. General Mills, Inc., Case No. 10-00061-CJC(ANx), and is in the United States District Court for the Central District of California. The Court decided this lawsuit should be a class action on behalf of a “Class,” or group of people, that could include you.

The lawsuit claims that General Mills falsely advertised its Yo-Plus® brand of yogurt by claiming that Yo-Plus® yogurt provides digestive health benefits when General Mills didn’t have a scientific basis to make that claim. The Yo-Plus® lawsuit seeks the return of money to the purchasers and a court order prohibiting the advertising. General Mills denies it did anything wrong and says its Yo-Plus® advertising was truthful and always substantiated by scientific evidence.

The Court has not decided whether the Class or General Mills is right. The attorneys for the Class will have to prove their claims at a trial.

The Class, on whose behalf the lawsuit is brought, is defined as “All persons who purchased Yo-Plus® in the State of California from the date Yo-Plus® was first sold in California to the date notice is first provided to the Class.” You may be a Class Member and, if so, you have a choice of whether to stay in the Class or opt out–Yo-Plus® class action lawsuit claim information can be found here at the claims administrator’s site.

If you are included, you have to decide whether to stay in the Class and be bound by whatever results, or ask to be excluded and keep your right to sue General Mills. There is no money available now and no guarantee that there will be. To find out more by reading about the Yo-Plus® lawsuit here.

Top Settlements

Happy Honda–remember that slogan? No? Well, if you’re part of the Honda Hybrid class action lawsuit you may become a Happy Honda Owner. Maybe. This week, a proposed settlement was approved by a San Diego Superior Court judge in a consumer fraud class-action lawsuit brought by Honda car owners over allegations that Honda hybrid vehicles were not as fuel-efficient as advertised and had problems with battery life.

The Honda Hybrid settlement affects some 460,000 owners and lessees of Honda Civic Hybrids and includes model year vehicles from 2003 to 2009. This is the Honda lawsuit, if you recall, in which Heather Peters of California opted out of the Honda class action lawsuit in order to sue Honda on her own.

According to the terms of the settlement, each class member is entitled to a $100 cash payment and a rebate certificate valued at $500 or $1,000.

Folks who make up a subclass of the lawsuit, who experienced car problems caused by a software upgrade, could receive an additional $100 and an additional $500 rebate, according to reports. Software upgrades–aren’t they just the bane of modern day existence. I digress.

In any event, court documents would indicate the total settlement could reach $461.3 million, and includes a net award of attorney fees of more than $8.1 million.

OK –That’s a wrap. Happy Friday everyone – see you at the bar!

Week Adjourned: 2.24.12

The weekly wrap of top class action lawsuits and lawsuit settlements for the week ending February 24, 2012.

Top Class Actions

Hotels.com—too good to be true? Kaylen Silverberg thinks so. She filed a consumer fraud class action lawsuit this week against the online booking agency, alleging it does not back up its promise to refund money if hotel guests can find a better rate elsewhere online.

Instead, Silverberg’s lawsuit claims, Hotels.com sets an “arbitrary and undisclosed limit” on refunds.

Silverberg’s lawsuit states Hotels.com will not back up its promise: “‘after you book with Hotels.com, if you find a lower publicly available rate on line for the same dates, hotel, and room category, we will match the price and refund you the difference.'” Instead, the lawsuit states, “Hotels.com has an arbitrary and undisclosed policy to refund only a portion of the difference between its rate and other, lower rates. For example, in Silverberg’s case, Hotels.com stated that ‘we can only refund you $142,’ even though the price difference was substantially greater.”

Silverberg’s story, short version, is allegedly that she booked a room through Hotels.com for two nights in Rancho Palos Verdes, CA., for $355 per night, then found a $223 rate at HotelClub.com. A third website advertised an even lower rate, $213. Silverberg then asked Hotels.com to back up its guarantee but she was told by the company that they would refund her only $71 a night, which she calls “an arbitrary and undisclosed limit.”

The lawsuit seeks restitution and class damages for breach of contract and unjust enrichment—otherwise known as “business as usual.”

Top Settlements

Every so often a class action settlement comes along that results directly from very unfortunate circumstances. This is one such settlement. This week, Teva Pharmaceuticals, the maker of Propofol, announced it will settle 120 personal injury lawsuits arising from a hepatitis C outbreak in Southern Nevada. The amount of the Nevada Propofol settlement is a reported $285 million.

The Israeli-based generic drug maker was facing lawsuits brought by some 150 former patients of The Endoscopy Center of Southern Nevada and its sister clinics, who contracted the disease after receiving propofol at the clinics. LAS reported on this in some detail at the time.

According to a report in the Las Vegas Review Journal, nine hepatitis C cases were found to be linked to the clinics which were run by Dr. Dipak Desai. Seven of the nine cases were genetically linked to the center. Health officials called another 106 cases “possibly linked.” According to health officials, more than 60,000 former clinic patients were potentially exposed to hepatitis C because of unsafe injection practices by nurse anesthetists at the clinics.

Teva lost the first three trials and was facing payments of nearly $800 million dollars in compensatory and punitive damages. The fourth trial was under way when settlement talks began in earnest. The settlement leaves 15 lawsuits unresolved.

Antennagate may be drawing to a close…if a preliminary settlement reached in a defective products class-action lawsuit against Apple is approved. The lawsuit alleges underperformance of its iPhone 4 resulting from antenna problems. And oh brother did we ever hear about it! While the iPhone 4 settlement per class member is certainly not large, by anyone’s measure—the size of the class certainly is—25 million US residents no less, each of whom could receive $15 in cash or a bumper case provided by Apple under the terms of the settlement. So, don’t be quitting your day job just yet.

The class action combined 18 separate lawsuits, all of which allege Apple was “misrepresenting and concealing material information in the marketing, advertising, sale, and servicing of its iPhone 4—particularly as it relates to the quality of the mobile phone antenna and reception and related software.”

As part of the iPhone 4 settlement original purchasers will be sent emails before April 30, 2012 alerting them to the settlement. The claims period is then open for 120 days.

OK—And it’s off to the bar we go. See you there!

Week Adjourned: 1.21.12

A weekly wrap up of top class action lawsuits and settlements for the week ending January 21, 2012

Top Class Actions

Holy HELOC Batman—It’s been certified! A class action lawsuit brought by a couple in Cupertino in 2009—and which has been through 4 attempts to get certified—finally got the nod from a federal court judge this past week. And this one could affect many people.

The back story—Washington Mutual and JPMorgan Chase (Chase has since acquired WaMu) allegedly reduced credit limits on Jeffrey and Jenifer Schulken’s home equity line of credit (HELOC) without valid reasons.

Specifically, the HELOC class action lawsuit alleges violations of the Truth in Lending Act violations and unfair competition among other claims. The Cupertino couple allege they were informed by Chase, by letter, that their home equity credit lines would be suspended because they did not have enough monthly income to satisfy their debts. The Schulken’s allege that the monthly income of $11,200 that Chase claimed the couple stated on their applications, was inaccurate, that they had never “provided such an inflated income figure to WaMu, and that if the Schulkens’ file indicated such an income, then WaMu had intentionally misrepresented their income.”

After four attempts by Chase to have the complaint dismissed, two classes have now been certified: the “inability to verify” class, and a subclass of borrowers whose credit lines were suspended because Chase could not verify their financial circumstances.

The plaintiffs’ class definition to include “only those members who signed contracts that (1) arise from heritage WaMu customers, and (2) state that the borrower must provide, upon the lender’s request, ‘a current financial statement, new credit application, or both.'”

Top Settlements

Couple of big pharma settlements announced this week…

At the top of the hit parade we have Johnson & Johnson (J&J). They have reportedly agreed to pay $158 million to settle a lawsuit in Texas that alleges the company defrauded the state by misleading doctors about its antipsychotic drug Risperdal.

The deal will put an end to claims that J&J marketed Risperdal off label—for unapproved uses—and downplayed health risks associated with the drug. Texas had originally sought at least $579 million in damages. Well, shoot for the stars—isn’t that how the saying goes?

Bloomberg reported that the settlement follows some rather incriminating testimony given in court last week. Testimony that included an expert eye witness stating that J&J hid data showing Risperdal could cause weight gain that could lead to diabetes. According to Bloomberg “the witness also alleged that J&J had key study [ Study 113] results several years before it added warnings about weight gain to the drug’s label.”

Bloomberg notes in its report that J&J’s unpublished studies—ah—yes—more than one—were cited in a South Carolina case that brought a $327 million judgment against the pharmaceutical manufacturer. “It is apparent to this court that this information was not disclosed because if did not fit the marketing department’s vision for the promotion and marketing of this drug,” Judge Roger Couch wrote in a ruling (as quoted by Bloomberg). Amen to that.

And singing from a similar song sheet—we have Merck. It was announced this week that they have agreed to pay up to $37 million to settle a Canadian Vioxx class action lawsuit. Included in the settlement is $10 million for costs and fees. Plaintiffs’ lawyer said up to 2,000 Canadians may be eligible for compensation.

FYI—Vioxx (Rofecoxib) was on the market from 1999 to 2004, prescribed to patients as a pain-reliever for arthritis, osteoarthritis, menstrual pain, and other acute pain. Vioxx was recalled and pulled off the market when it was linked to deadly side effects heart attack, stroke, kidney damage, and arrythmia. This led to billions of dollars’ worth of litigation, including a $4.85 billion settlement that covers most of the U.S. plaintiffs.

Ok—That’s a wrap for this week. See you at the bar!

Week Adjourned: 12.17.11

A wrap of the top class action lawsuits and settlements for the week ending December 17, 2011.

Top Class Actions

What Happened to that ‘Good Will Toward Men’ Thing? ‘Tis the season–and this thing called good will towards men apparently hasn’t caught on yet–in some parts. Case-in-point–Capital One. They’re facing a class action over allegations that they illegally obtain background checks on folks applying for jobs with the company. What’s in your wallet indeed!

The lawsuit was filed on behalf of Plaintiff Kevin Smith and seeks to represent a class of all Capital One employees and job applicants for the past three years.

Essentially, the lawsuit accuses Capital One of violating the Fair Credit Reporting Act (“the Act”) Act in a two ways. First, the lawsuit alleges that Capital One’s authorization form is flawed. The law imposes strict formatting requirements on companies who do background checks. The lawsuit alleges that by burying its background check authorization in a job application, including extraneous information, Capital One violated the law. On this claim, Capital One may be liable to all employees and prospective employees who signed Capital One’s standard job application.

Second, the lawsuit also alleges that Capital One failed to provide copies of the reports when it used them to take adverse employment actions, such as refusing to hire an applicant, refusing to promote an employee or terminating an employee. This practice also violates the Act, which requires companies to provide employees with copies of their background checks.

The lawsuit is potentially valuable to class members. Employees and prospective employees may be entitled to statutory damages of up to $1,000 for each violation. “Based on our understanding of Capital One’s practices, everyone who has applied or worked for Capital One in the past three years should be eligible to receive statutory damages if our lawsuit succeeds,” attorneys for the plaintiff(s) state.

Next up–Apple. All I have to say about this is Really? Here’s the skinny…

Cheap to the (Apple) Core? The uber cool icon of new technologies for the 21st century has been hit with an employment class action lawsuit. The suit alleges that Apple devised an illegal scheme of classifying at-home call center employees as independent contractors in order to avoid paying Apple’s share of payroll taxes and other business related expenses through the use of a Yellow Dog Contract.

According to the lawsuit, Apple “hires workers to answer calls from its customers in regard to billing questions and technical support” but has devised an unlawful scheme of classifying the employees as independent contractors in order to avoid paying for regular and overtime hours worked as well as the “the cost of the employer’s share of tax payments to the federal and state governments for income taxes, social security taxes, medicare insurance, unemployment insurance and payments for workers’ compensation insurance.” The complaint specifically alleges that in order to avoid the payment of these costs as required by law, the at home call center employees “are required by APPLE to each form a separate Virtual Services Corporation to act as a shell corporation as part of the scheme to insulate APPLE from APPLE’s liability for APPLE’s Business Related Expenses.” The class action lawsuit against Apple refers to these agreements between Apple and the employees as “Yellow Dog Contracts” that violate not only employment laws, but also fundamental public policy.

Top Settlements

A Fee-for-All at Walmart? Walmart has agreed to a $13.5 settlement of a securities class action this week. The lawsuit was brought by employee Jeremy Braden, and others, who alleged that the retail giant, together with Bank of America’s Merrill Lynch unit, passed along “unreasonably high fees and expenses” to its 2 million workers who had 401(k) plans. As with many 401(k) plans, Walmart’s contained a mixture of mutual funds representing investments in the bond and stock markets. The costs of managing those funds were passed along to employees.

According to a report in the AARP Bulletin the Walmart “settlement is a legal landmark because Walmart provides one of the largest 401(k) plans in the world and is the nation’s largest private employer, with more than $400 billion in annual sales.”

The timing is interesting in that the US Department of Labor is currently refining regulations around “fiduciary duty” and fee disclosure in 401(k) plans. And, the government is pressing for full disclosure of all fees paid to middlemen such as savings plan managers and wants stricter legal guidelines on how to provide the most prudent offerings at the lowest possible cost.

“I believe my account has experienced a loss in value, due to the reduced return on my investment in those plan investment options caused by the unreasonably high fees and expenses in those funds,” Braden stated in the lawsuit.

Under the terms of the settlement, Braden will collect $20,000. “Other employees covered by the class action suit will not receive payouts, but will benefit in the form of up to $9 million in reduced fees going forward. Lawyers for the plaintiffs will collect as much as $4 million,” AARP Bulletin reported.

Ok–That’s enough for this week. See you at the bar.

Week Adjourned: 11.4.11

Week Adjourned: the weekly wrap of class action lawsuits and settlements, November 4, 2011

Top Class Actions

Could this mean resolution for thalidomide victims?…New research suggests that thalidomide—a drug that caused thousands of horrific cases of deformities in children—caused far more deformities in the U.S. than were reported during the height of the pharmaceutical crisis of the early 1960s.

Invented by German drug company Grunenthal, thalidomide was widely used throughout Europe during the late 1950s and early 1960s, resulting in thousands of deaths and extreme, disfiguring birth defects when used by women during pregnancy. The drug was never approved in the United States, but the new lawsuit filed late October 2011 alleges that as many as 2.5 million doses of the drug were distributed by more than 1,200 doctors to more than 20,000 people, including pregnant women.

Newly discovered and translated documents reveal that Smith, Kline and French (SKF), now owned by GlaxoSmithKline (GSK)conducted a trial of the drug in 1956 and 1957, but buried the evidence, allegedly resulting in a missed opportunity to save thousands of lives.

Instead, according to the filed lawsuit, brought on behalf of 13 men and women with severe birth defects, SKF concealed the results of its trial from the public, allowing another company, Richardson-Merrell, now owned by Sanofi-Aventis to move ahead with large-scale “clinical trials” that involved more than 20,000 people, including pregnant women.

The lawsuit also claims that conclusions made in the early 1960s about the types of birth defects caused by the thalidomide were incorrect.

According to legal counsel, researchers concluded that thalidomide causes bilateral birth defects, such as two missing or shortened arms or hearing loss in both ears. As a result, babies born with unilateral defects, such as one deformed limb, or hearing loss in only one ear were not deemed thalidomide victims, even when their mothers were given the drug while pregnant.

However, new research involving thalidomide as part of a treatment regimen in cancer patients show that many of the assumptions used in the 1960s are incorrect. The thalidomide lawsuit alleges that this new understanding of the drug means that many individuals who experienced unilateral defects may have been misdiagnosed when their doctors told them thalidomide could not have been the cause.

“Among other things we intend to show in court that thalidomide does not work through a neural mechanism as previously thought, but affects the vascular system,” a lawyer for the plaintiffs said.

The complaint claims that the defendants are either guilty of or liable for a civil conspiracy, failing to report and covering up evidence that thalidomide was harmful, especially when taken during the early stages of pregnancy. The lawsuit also says that the defendants were negligent in continuing to manufacture, test and distribute the drug.

Top Settlements

Motrin SJS Verdict. This is one for the books. Let’s hope it makes a difference. On October 3, 2011, a Los Angeles jury returned a record-setting verdict against Johnson & Johnson and their fully owned subsidiary McNeil Consumer Healthcare for $48.2 million—with pre-interest and cost of judgment it’s expected to reach $60 million. The lawsuit alleged that Motrin caused SJS/TENS or Stevens Johnson Syndrome (SJS), also known as Erythema Multiforme, Leyll’s Syndrome, and in its later stages, Toxic Epidermal Necrolysis (TEN). SJS/TEN is a serious and potentially life-threatening disease that causes large areas of the skin to become detached and lesions to develop in the mucous membranes.

The verdict was based on findings of malice towards the consumers of the over-the-counter drug Motrin, specifically for not putting a warning label on the product that could have spared Trejo’s and others’ health. This is believed to be the first verdict of its kind involving punitive damages associated with this over-the-counter temporary pain reliever.

At age 16, Christopher Trejo, who is now 22 years old, took some Motrin as directed on the label for less than one week, but contracted TEN. It caused a severe inside-out exfoliating reaction affecting all of his mucosal membranes, which is equivalent to second- and third-degree burns over 100% of his body. The TEN reaction also caused severe pulmonary damage, near-blindness, infertility, whole-body scarring and a hypoxic brain injury. Trejo’s abilities to see, hear, smell, taste and touch have been severely diminished.

After hearing the evidence, the jury found that the labeling on Motrin was inadequate and should have been changed years earlier to properly educate and alert consumers to the developing signs of severe reactions, which include skin reddening, rash and blisters. Early detection and treatment of these symptoms can prevent TEN or SJS.

Apple Playing the Same Old tune? Apple, Inc., has agreed to settle a consumer fraud class action lawsuit that could amount to over $50 million dollars in payouts—but before you get all excited know this “Apple has agreed to provide an iTunes® Store credit in the amount of $3.25 to all settlement class members who qualify and submit a valid claim form. ” That’s the skinny.

The lawsuit claimed that Apple advertised and sold gift cards which stated that if one purchased and used the gift card, all songs purchased at Apple’s online iTunes® Store would cost 99¢ per song. The lawsuit further claimed that in April, 2009, Apple raised the price of certain songs at the iTunes® store, yet refused to honor the promised 99¢ price when the gift cards were redeemed. In addition, the company continued to sell iTunes® gift cards with the phrase, “Songs are 99¢” printed on them.

Consumers who were overcharged for iTunes songs while using iTunes® 99¢ gift cards are now eligible to receive an iTunes® Store credit in the amount of $3.25 after completing the simple iTunes® class action lawsuit online claim form. Millions of e-mails are currently being sent to persons who may have used affected gift cards to purchase songs from the iTunes® Store.

You can find out how to make an Apple iTunes lawsuit claim here.

Ok—That’s enough for this week. See you at the bar—don’t forget your iPod.